The goal of this pilot clinical trial is to assess the feasibility of conducting a full-scale study to learn if a new youth-adapted Narrative Enhancement and Cognitive Therapy (NECT-Y) reduces self-stigma in youth living with bipolar disorder or multiple mental health conditions. The main questions it aims to answer are: * What is the feasibility of conducting a definitive clinical trial in terms of recruitment success, study retention/compliance, treatment retention/compliance, and absence of serious adverse events? * Can facilitators deliver the adapted NECT-Y intervention with fidelity? * What is the acceptability of the newly adapted NECT-Y intervention among youth participants and facilitators? Researchers will compare NECT-Y to treatment as usual (TAU). Participants will take part in a virtual 14-week NECT-Y group intervention or receive TAU. They will also complete questionnaires at three time points (baseline, post-treatment, and follow-up).
Age range
16 Years – 29 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of Participants Providing Consent to Participate in the Study
Timeframe: Duration of the study enrollment period, up to 1 year
Number of Participants Providing Consent in Two Months
Timeframe: Duration of the study enrollment period, up to 1 year
Number of Sessions Attended by Participants Randomized to NECT-Y
Timeframe: From week 1 to week 14 of the NECT-Y intervention, up to 14 weeks
Number of Participants Completing Study Questionnaires at Week 15
Timeframe: Week 15 (post-treatment)
Number of Participants Completing Study Questionnaires at Week 28
Timeframe: Week 28 (3-month follow up)
Number of Questionnaires Completed at Week 15
Timeframe: Week 15 (post-treatment)
Number of Questionnaires Completed at Week 28
Timeframe: Week 28 (3-month follow up)
Number of Participants With Study-Related Adverse Events as Assessed by an Institutional Adverse Event Log
Timeframe: From study enrollment to 3-month follow up, up to 28 weeks